Drug archive
Gonadorelin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Diagnostic aid, hypothalamic-pituitary-gonadal axis function
- Gonadotropin-releasing hormone
- Infertility therapy agent
Description
Gonadorelin (goe-nad-oh-RELL-in) is a medicine that is the same as gonadotropin-releasing hormone (GnRH) that is naturally released from the hypothalamus gland. GnRH causes the pituitary gland to release other hormones (luteinizing hormone [LH] and follicle-stimulating hormone [FSH]). LH and FSH control development in children and fertility in adults.
Gonadorelin is used to test how well the hypothalamus and the pituitary glands are working. It is also used to cause ovulation (release of an egg from the ovary) in women who do not have regular ovulation and menstrual periods because the hypothalamus gland does not release enough GnRH.
Gonadorelin may also be used for other conditions as determined by your doctor.
Gonadorelin is available in the following dosage form:
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Factrel
In Canada -
- Factrel
- Lutrepulse
- Relisorm
Other commonly used names are luteinizing hormone-releasing hormone (LHRH), luteinizing hormone-releasing factor dihydrochloride (for gonadorelin hydrochloride), luteinizing hormone-releasing factor diacetate tetrahydrate (for gonadorelin acetate), and luteinizing hormone-/follicle-stimulating hormone-releasing hormone (LH/FSH-RH).